Skip to main content

Enterobacteriaceae Antimicrobial Agents and Resistance: Relationship with the Therapeutic Approach, Volume II

92kviews
Editorial: Enterobacteriaceae antimicrobial agents and resistance: relationship with the therapeutic approach, volume II
Editorial18 January 2024
Editorial: Enterobacteriaceae antimicrobial agents and resistance: relationship with the therapeutic approach, volume II

harmful for the infections treatment thereby leading to a greater resistance selection (Laxminarayan et al., 2016). Consequently, antibiotics become ineffective increasing the risk of disease spread, severe illness and death (Palacios-Baena et al., 2021). New strategies should be taken into account in the therapeutic approach through enhancing host immunity mechanisms or relying on new compounds, such as essential oils (Oliva et al., 2018), N-acetylcysteine (Oliva et al., 2021), bacteriophages (Qin et al., 2021), vaccines (Diago-Navarro et al., 2017) or the combination therapy (Mascellino et al., 2021) (Figure 1).The presence of enzymes, such as Extended-Spectrum β-lactamase (ESBL) and carbapenemases (KPCs, Metallo β-lactamases, OXA, GES ), constitutes the principal resistance mechanism to antibiotics. (Scudeller et al., 2021).A new metallo βlactamase , called SZM-1, is identified and characterized in Shenzhen Bay, South China by Lingxu Fang (https://www.frontiersin.org/articles/10.3389/fmicb.2022.996834/full). This Shenzhen metallo-β-lactamase belonging to an Arenimonas metagenome-assembled genome recovered from the river sediment in the Shenzhen Bay area, shows carbapenemase activity, and confers an increasing resistance towards carbapenems in the carrier bacteria.In order to test the most common resistance genes (blaKPC, blaNDM- In the first one, it is noticed that the extended-spectrum β-lactamase-producing Enterobacteriaceae colonization does not interfere with either following infections by ESBL Gram-negative bacteria or with liver transplant outcomes. Consequently, this colonization cannot be considered a risk factor for possible post-transplant Gram-negative infections even if some previous literature data provide conflicting results mainly for Gram-positive bacteria (Russel et al., 2008) In the second article, the outbreak of carbapenem-resistant Enterobacteriaceae in a thoracic-oncology unit is taken into consideration. The study includes Citrobacter freundii and E. hormaechei (both belonging to Enterobacter cloacae complex) producing OXA-48 carbapenemase in hospitalized patients.The blaOXA-48 gene is disseminated by both clonal and plasmid spread. The origin of this outbreak appears to be both external and internal to the ward deducing that this cross-infection must be managed with the implementation of approppriate prevention and control measures.Lastly, an effective new strategy for fithing the antimicrobial resisrance (AMR) could rely on increasing host immunity by making people less receptive to infections and more ready to combat them. This In conclusion, the AMR is currently a crucial issue in the management of the infectious diseases worldwide. (Jamal et al., 2020). New antibiotics, antimicrobial associations, combinations between betalactams and beta-lactamases inhibitors are taken into account even if the bacterial resistance and the therapy failures are always lurking (Bhatnagar et al., 2021). Appropriate prevention and control measures should be greatly improved (van Seventer and Hochberg, 2017). This issue constitutes an increasing problem that requires drastic solutions for limiting the further spread of resistant bacteria. Alternative therapeutic programs could be proposed, such as using N-acetyl-cisteyne, bacteriophages and more importantly vaccines stimulating the immune response that can recognize different bacterial antigenic epitopes to promote pathogen elimination.

1,851 views

1 citations

ORIGINAL RESEARCH
19 September 2023
Colonization of extended-spectrum β-lactamase-producing Enterobacteriaceae does not affect subsequent infection and liver transplant outcomes: a retrospective observational cohort study
Chen Shang, 6 more and Yuxiao Deng

2,356 views

3 citations

ORIGINAL RESEARCH
28 June 2023
Optimal treatment of ceftazidime-avibactam and aztreonam-avibactam against bloodstream infections or lower respiratory tract infections caused by extensively drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa
Yixin Kang, 2 more and Junchang Cui

6,494 views

20 citations

ORIGINAL RESEARCH
3 May 2023
Efficacy and safety of piperacillin–tazobactam compared with meropenem in treating complicated urinary tract infections including acute pyelonephritis due to extended-spectrum β-lactamase-producing Enterobacteriaceae
Wei Zhang, 13 more and Jing-Wen Wang

13,070 views

14 citations

REVIEW
20 April 2023
Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis
Dan Li, 5 more and Jie Zhang
Objective: To analyze the mortality rate of patients with Klebsiella pneumoniae bacteremia (KPB) and the impact of extended spectrum beta-lactamase (ESBL) producing or carbapenem-resistance (CR) KP on the mortality rate among patients with bacteremia. Methods: EMbase, Web of Science, PubMed, and The Cochrane Library were searched up to September 18th, 2022. Two reviewers independently extracted data and evaluated risk of bias of included studies by ROBINS-I tool. A meta-regression analysis was conducted using a mixed-effects model to explore possible sources of heterogeneity. A random-effects model was used for pooled analysis in case of significant heterogeneity (I2>50%). Otherwise, the fixed-effects model was performed. Results: A total of 157 studies (37,915 enrolled patients) were included in the meta-analysis. The pooled death proportions of KPB were 17% (95% CI=0.14-0.20) at 7-day, 24% (95% CI=0.21-0.28) at 14-day, 29% (95% CI=0.26-0.31) at 30-day, 34% (95% CI=0.26-0.42) at 90-day, and 29% (95% CI=0.26-0.33) in hospital, respectively. Heterogeneity was found from the intensive care unit (ICU), hospital-acquired (HA), CRKP, and ESBL-KP in the meta-regression analysis. More than 50% of ICU, HA, CRKP, and ESBL-KP were associated with a significant higher 30-day mortality rates. The pooled mortality odds ratios (ORs) of CRKP vs. non-CRKP were 3.22 (95% CI 1.18-8.76) at 7-day, 5.66 (95% CI 4.31-7.42) at 14-day, 3.87 (95% CI 3.01-3.49) at 28- or 30-day, and 4.05 (95% CI 3.38-4.85) in hospital, respectively. Conclusions: This meta-analysis indicated that patients with KPB in ICU, HA-KPB, CRKP, and ESBL-KP bacteremia were associated with a higher mortality rate. The high mortality rate caused by CRKP bacteremia has increased over time, challenging the public health.
Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis

25,194 views

132 citations

ORIGINAL RESEARCH
12 January 2023
Development of a novel loop-mediated isothermal amplification assay for ß-lactamase gene identification using clinical isolates of Gram-negative bacteria
Eun Jin Kim, 16 more and Mitsuko Seki

5,981 views

19 citations

ORIGINAL RESEARCH
9 December 2022
A comprehensive description of the TolC effect on the antimicrobial susceptibility profile in Enterobacter bugandensis
Bingyu Li, 1 more and Xiaodong Li

5,911 views

7 citations

ORIGINAL RESEARCH
7 December 2022
Outbreak of carbapenem-resistant enterobacteria in a thoracic-oncology unit through clonal and plasmid-mediated transmission of the blaOXA-48 gene in Southern France
Linda Hadjadj, 6 more and Sophie Alexandra Baron

5,630 views

15 citations